ABBVIE INC.

CPT · Copyright/Patent/Trademark

S.1040, Drug Competition Enhancement Act Patent litigation reform issues and issues related to post-grant proceedings at the USPTO Value of intellectual property

Literal federal measure citations: S.1040

HCR · Health Issues

S. 864, HELP Copays Act H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act S. 2903, Safe Step Act H.R. 5509, Safe Step Act H.R. 8630, The Protecting Equal Access to Thyroid Act of 2026 Drug cost and pricing policy issues Patient affordability issues Issues related to the 340B program Issues related to data privacy Issues related to FDA communications

Literal federal measure citations: S. 864, H.R. 4299, S. 2903, H.R. 5509, H.R. 8630

MMM · Medicare/Medicaid

Public Law 117-169 (formerly known as H.R. 5376, Inflation Reduction Act) Implementation regarding Medicare Part D drug negotiation program Policy Proposals related to Medicare Part D and patient cost-sharing Department of Health and Human Services (HHS) drug policy issues and regulatory policy issues Issues related to HCV treatment

Literal federal measure citations: H.R. 5376

TAX · Taxation/Internal Revenue Code

H.R. 1328, Supply Chain Security and Growth Act of 2025 H.R. 1990, American Innovation and R&D Competitiveness Act of 2025 Public Law No: 119-21 (formerly known as H.R. 1, One Big Beautiful Bill Act) Implementation Public Law 115-97 (formerly known as H.R. 1, Tax Cuts and Jobs Act) Implementation Policy proposals relating to economic activity in Puerto Rico International tax issues, including OECD digital taxation work program

Literal federal measure citations: H.R. 1328, H.R. 1990, H.R. 1, H.R. 1

LBR · Labor Issues/Antitrust/Workplace

Issues related to antitrust and competition policy

TRD · Trade (domestic/foreign)

Issues related to pharmaceutic tariffs and unfair trade practices Issues related to U.S. biotech competitiveness with China